Clinical trial for ADHD
Official title Fidgeting and Attentional and Emotional Regulation in ADHD
ClinicalTrials.gov ID: NCT04526600
What this study is testing
- What it's testing
- The study wants to see whether moving or using a fidget device can improve thinking and emotional control in adults with ADHD, and to collect data for future research.
- Who it's for
- Adults who have been diagnosed with attention‑deficit/hyperactivity disorder (ADHD).
- What's involved
- Participants will be in a lab, move around or use a fidget device while researchers measure their thinking, emotions, and body signals. They may also have their movements recorded for analysis.
- Time commitment
- The study lasts a few hours in a single lab visit, with no long‑term follow‑up required.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 30
You may be able to join if
- ADHD
- History of fidgeting
You likely can't join if
- Currently taking psychoactive medication, with the exception of stimulant medication for ADHD or medication that can affect heart rate;
- Presence of significant depression or psychotic disorders, autism, visual or hearing impairment or any other disorder that may interfere with task...
The study team makes the final eligibility decision.
Where it is enrolling
- Sacramento, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 30 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Sacramento, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.